tiprankstipranks
XOMA Royalty Corporation (XOMA)
NASDAQ:XOMA

Compare XOMA Royalty Corporation (XOMA) vs. Competitors

426 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
XOMA Royalty Corporation
$38.65
$437.41M
15.08
93.54%
2 Buy
1 Hold
0 Sell
Moderate Buy
Ocugen
$1.79
$577.10M
-5.95
159.42%
6 Buy
0 Hold
0 Sell
Strong Buy
Corvus Pharmaceuticals
$15.17
$1.27B
-39.78
409.06%
5 Buy
0 Hold
0 Sell
Strong Buy
Monte Rosa Therapeutics
$17.55
$1.40B
-33.72
315.88%
6 Buy
0 Hold
0 Sell
Strong Buy
Inhibrx Biosciences Inc
$85.32
$1.10B
567.18%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
XOMA
XOMA Royalty Corporation
38.65
17.85
85.82%
OCGN
Ocugen
1.79
1.09
156.45%
CRVS
Corvus Pharmaceuticals
15.17
11.93
368.21%
RAPT
GLUE
Monte Rosa Therapeutics
17.55
13.12
296.16%
INBX
Inhibrx Biosciences Inc
77.46
65.67
557.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts